Literature DB >> 7150344

Polymorphic sulphoxidation of S-carboxymethyl-L-cysteine in man.

R H Waring, S C Mitchell, R R Shah, J R Idle, R L Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7150344     DOI: 10.1016/0006-2952(82)90102-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  13 in total

1.  Does sulphoxidation state predict gold toxicity in rheumatoid arthritis?

Authors:  R Madhok; H A Capell; R Waring
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-21

2.  Evaluation of proposed sulphoxidation pathways of carbocysteine in man by HPLC quantification.

Authors:  J Brockmöller; B Staffeldt; I Roots
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  HLA-DR antigens in rheumatoid arthritis. A Swiss collaborative study; final report. Swiss Federal Commission for the Rheumatic Diseases, Subcommission for Research.

Authors: 
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

4.  Odorous urine following asparagus ingestion in man.

Authors:  S C Mitchell; R H Waring; D Land; W V Thorpe
Journal:  Experientia       Date:  1987-04-15

5.  Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.

Authors:  S C Mitchell; R H Waring; C S Haley; J R Idle; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

6.  Pharmacokinetics of N-propylajmaline in relation to polymorphic sparteine oxidation.

Authors:  C Zekorn; G Achtert; H J Hausleiter; C H Moon; M Eichelbaum
Journal:  Klin Wochenschr       Date:  1985-11-15

7.  An investigation of the metabolism of S-carboxymethyl-L-cysteine in man using a novel HPLC-ECD method.

Authors:  E F Karim; J S Millership; D J Temple; A D Woolfson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Oct-Dec       Impact factor: 2.441

8.  Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man.

Authors:  A Küpfer; R Preisig
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Reduced sulphoxidation capacity in D-penicillamine induced myasthenia gravis.

Authors:  P Seideman; R Ayesh
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

10.  Pharmacokinetics of albendazole in man.

Authors:  S E Marriner; D L Morris; B Dickson; J A Bogan
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.